Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatinib plus PD-1 Inhibitors
ETS of 10% and DoR of 27% were identified as the optimal cutoffs for predicting the clinical outcomes of patients with uHCC treated with TACE and lenvatinib plus a programmed death-1 inhibitor.
Authors
- Xiaobing Zhang (ORCID: https://orcid.org/0000-0002-1171-0740)
- Dong Wu (ORCID: https://orcid.org/0000-0001-7781-1010)
- Zhemin Shen (ORCID: https://orcid.org/0000-0002-8043-5228)
- Shuping Qu (ORCID: https://orcid.org/0000-0001-7086-1541)
- Hongyu Pan (ORCID: https://orcid.org/0000-0002-5605-5380)
- Yalin Chen (ORCID: https://orcid.org/0000-0002-4265-1018)
Institutions
- Second Military Medical University (CN)
- Shanghai Cancer Institute (CN)
Publication Details
- Journal
- Oncology Research and Treatment
- Published
- 2025-03-12
- DOI
- https://doi.org/10.1159/000545210
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32